DUBAI, United Arab
Emirates and LA JOLLA, Calif., Sept. 22, 2016 /PRNewswire/ -- Cerus
Advisors DMCC, (Cerus), a boutique private equity management
and advisory firm focused on long-term value creation in life
sciences and real estate, has launched global operations. Cerus
provides funding and experienced-based, strategic support to its
portfolio companies to guide their growth. The firm is led and
managed by a team of highly experienced professionals and
entrepreneurs with a long standing track record in investment
management and operations. The team includes Marios Fotiadis, M.B.A, Kleanthis G. Xanthopoulos, Ph.D., Gabriela M. Le
Henand, and Riccardo Ricciardelli,
M.B.A.
"We know from our collective experience that the intrinsic value
of a company needs to be protected through the right financial,
operational and strategic guidance," said Marios Fotiadis, M.B.A., Chairman, Manager
Partner. "Cerus' business model is enhanced through our ability to
deploy funding as well as strategic and operational value to our
portfolio companies by utilizing our unique platform. We look
forward to establishing Cerus as the global partner of choice to
entrepreneurs who align with our investment philosophy and
vision."
"The life sciences industry is an incredibly fascinating,
innovative and very fast growing global enterprise. Recent
scientific advances have opened new dimensions in drug discovery
and medical technologies based on the industry's desire to
innovate. By contrast, the way we build and capitalize life
sciences companies has remained stagnant, with venture and private
capital serving as the most common way to enable growth
opportunities," said Dr. Kleanthis G.
Xanthopoulos, Managing General Partner. "With the birth
of Cerus, we intend to create an alternative to the traditional
investment models to keep pace with our industry and create
long-term value for our founding entrepreneurs and syndicated
investors."
The team seeks life science opportunities with technologies and
concepts that address unmet medical needs, have high-value
supportive intellectual property, and are in attractive therapeutic
areas. In real estate, the team is focusing on commercial growth
opportunities.
About Cerus Advisors – a New Breed of Investor
Cerus DMCC is the strategic investment arm of a single-family
office with global investments, focused on the pharmaceutical,
medical device, health care and real estate industries. Cerus has
leveraged its extensive investment and deal-making expertise to
work with other family offices and third-party institutional
investors to create valuable syndications around high-value growth
opportunities. Cerus' investment philosophy is rooted in its DNA as
a single-family office advisor - therefore, every transaction is
viewed with only one objective: Long-Term Value
Creation. To achieve this objective, Cerus has developed
a highly customized advisory practice that guides its portfolio
companies and global partners in seeking private equity
investments, deploying private equity resources and structuring
highly customized private transactions. Cerus has investment
offices in Dubai, UAE and in
La Jolla, California,
USA. For more information, please visit
www.cerusadvisors.com.
The name Cerus stems from Greek Mythology - the goddess
of Spring, Persephone, befriends a wandering bull known as Cerus
and teaches the bull patience, perseverance and how to use his
strength wisely. Cerus applies this spirit to its investment
strategies with careful, reliable and patient value creation
focused on long-term growth.
Contact:
Amy Conrad
Juniper Point
amy@juniper-point.com
858-366-3243
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cerus-advisors-dmcc-is-launched-creating-a-new-investment-model-300332248.html
SOURCE Cerus Advisors DMCC